The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Attenuated regimen of biweekly gemcitabine/nab-paclitaxel in patients aged > 65 years with advanced pancreatic cancer (APC).
 
Hasan Rehman
No Relationships to Disclose
 
Jeffrey Chi
No Relationships to Disclose
 
Nausheen Hakim
No Relationships to Disclose
 
Shreya Prasad Goyal
No Relationships to Disclose
 
Coral Olazagasti
No Relationships to Disclose
 
Jyothi Jose
No Relationships to Disclose
 
Linda Moriarty
No Relationships to Disclose
 
Wasif M. Saif
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene
Speakers' Bureau - Amgen; Amgen; Amgen; Amgen; Celgene; Celgene; Celgene; Celgene; Genentech; Genentech; Genentech; Genentech; Ipsen; Ipsen; Ipsen; Ipsen; Lexicon; Lexicon; Lexicon; Lexicon; Novartis; Novartis; Novartis; Novartis; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); ImClone Systems (Inst); ImClone Systems (Inst); ImClone Systems (Inst); ImClone Systems (Inst); Lexicon; Lexicon; Lexicon; Lexicon; NanoCarrier; NanoCarrier; NanoCarrier; NanoCarrier; Pharmacyclics; Pharmacyclics; Pharmacyclics; Pharmacyclics; Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)